Industry News
Anti-Cancer Properties Of Soybeans Highlighted In New Study
Mar 22, 2013
First study to report that proteins found in soybeans, could inhibit growth of colon, liver and lung cancers, published in Food Research International. Soybean meal is a bi-product following oil extraction from soybean seeds... Read More
New Smartphone App 'Detects' Skin Cancer
Mar 22, 2013
A new smartphone app that claims to detect warning signs of skin cancer has just been launched in the UK market following a two year beta in the U.S. The novel app, called Mole Detect Pro, provides its users with a remote professional diagnosis within 24 hours... Read More
Cod-Derived Agent Shows Potential As Dietary Therapy To Complement Standard Treatments For Prostate Cancer
Mar 22, 2013
Researchers at the University of Maryland School of Medicine have identified a peptide, or protein, derived from Pacific cod that may inhibit prostate cancer and possibly other cancers from spreading, according to preclinical research published online in the Proceedings of the National Academy of Sciences (PNAS)... Read More
Colorectal Cancer Highlighted In The March GIE: Gastrointestinal Endoscopy
Mar 22, 2013
In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer. The issue includes a practical guide for approaching and managing serrated colon polyps, one of the most common types of polyps, and a study on reducing postpolypectomy bleeding with prophylactic clip closure... Read More
Vitamin D Supplements May Offer Immune Benefits, Even In Healthy Individuals
Mar 22, 2013
Research from Boston University School of Medicine (BUSM) shows that improving vitamin D status by increasing its level in the blood could have a number of non-skeletal health benefits... Read More
Cell Therapy Shows Promise For Advanced Leukemia In Adults
Mar 21, 2013
An experimental therapy that alters cancer patients' own immune cells to identify a dangerous type of leukemia has also reduced tumors and sent the cancer into remission in adults, according to a new study published in Science Translational Medicine... Read More
UCLA Researchers Monitor T Cell Function To Improve Melanoma Treatment
Mar 21, 2013
UCLA and California Institute of Technology scientists from the UCLA Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research (Broad Stem Cell Research Center [BSCRC]) and the Jonsson Comprehensive Cancer Center (JCCC) led by James Heath, member of both centers, professor of molecular & medical pharmacology at UCLA and professor of chemistry at Caltech, have... Read More
Functional Characteristics Of Antitumor T Cells Change With Increasing Time After Therapeutic Transfer
Mar 21, 2013
Beneficial effect of genetically engineered antitumor T cells was transient. Functionality of T cells changed over time. Strategies are needed to sustain antitumor functionality. Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time... Read More
Virus-Based Melanoma Drug Shows Promise In Trial
Mar 21, 2013
For the first time in a late stage trial, a virus-based cancer drug is showing some promising early results. The news that Amgen's melanoma drug talimogene laherparepvec (TVEC) has met the primary goal of a Phase 3 trial may revive interest in what has proved to be a rather elusive drug technology... Read More
Cancer Scientists Discover Mechanism Of Resistance To Vital Leukaemia Treatment, Opening Door To New Therapies
Mar 21, 2013
Research published in the journal Cancer Cell has revealed the mechanism by which leukaemia cells develop resistance to the ATRA (All-Trans-Retinoic Acid) treatment, used to treat an aggressive form of cancer called acute promyelocytic leukemia (APL: a fast-growing cancer in which there are too many immature blood-forming cells in the blood and bone marrow)... Read More
Previous Page Next Page